ArticleDisease markers2022

Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker.

Zhitong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.